Gilead and Tango Collaboration Agreement in Targeted Immuno-Oncology Treatments

Wilson Sonsini Goodrich & Rosati is representing Tango Therapeutics in the transaction. Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics, Inc., a company focused on the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now